RESOLUTIONS OF MARIMEKKO CORPORATION’S ANNUAL GENERAL

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

Apr 6, 2017 at 10:00 AM 30

RESOLUTIONS OF MARIMEKKO CORPORATION’S ANNUAL GENERAL MEETING AND BOARD OF DIRECTORS’ CONSTITUTIVE MEETING

Marimekko Corporation, Stock Exchange Release, 6 April 2017 at 4.25 p.m. RESOLUTIONS OF MARIMEKKO CORPORATION’S ANNUAL GENERAL MEETING AND BOARD OF DIRECTORS’ CONSTITUTIVE MEETING At Marimekko Corporation’s Annual General Meeting, held today, and at the subsequent constitutive meeting of the Board of Directors, the following resolutions were passed. A. THE RESOLUTIONS OF ANNUAL GENERAL MEETING Adoption of the financial statements Marimekko Corporation’s income statement and balance sheet and the consolidated income statement and balance sheet for 2016 were adopted. Payment of the dividend The General Meeting approved the Board of Directors’ proposal to pay a dividend of EUR 0.40 per share for the 2016 financial year. The dividend will be paid to shareholders who are registered on the dividend payout record date of 10 April 2017 in the company’s Shareholder Register kept by Euroclear Finland Ltd. The dividend payout date is 19 April 2017. Discharge from liability The members of the Board of Directors and the President of the company were discharged from liability for the 2016 financial year. Remuneration of Board members The annual remuneration payable to the members of the Board was approved as follows: EUR 40,000 to the Chairman, EUR 30,000 to the Vice Chairman and EUR 22,000 to the other members of the Board. According to the resolution by the Annual General Meeting, approximately 40% of the annual remuneration will be paid in Marimekko Corporation’s shares acquired from the market and the rest in cash. The annual remuneration will be paid in cash in its entirety, if the Board member holds on the date of the Annual General Meeting, 6 April 2017, company’s shares in worth of more than EUR 500,000. The shares will be acquired directly on behalf of the Board members within two weeks from the release of the interim report for 1 January - 31 March 2017 or, if this is not possible taken into account the insider rules, as soon as possible thereafter. It was further resolved that no separate remuneration be paid for committee work to persons elected to any committee. In the remuneration payable to the Vice Chairman of the Board, the possible acting as the Chairman of the Audit and Remuneration Committee has been taken into account. Board of Directors The General meeting resolved that the company’s Board of Directors consist of seven members. Elina Björklund, Arthur Engel, Mika Ihamuotila, Mikko-Heikki Inkeroinen and Catharina Stackelberg-Hammarén were re-elected to the Board of Directors and Rebekka Bay and Helle Priess were elected as new members of the Board of Directors . Their term of office ends at the conclusion of the next Annual General Meeting. Election and remuneration of the auditor It was decided that PricewaterhouseCoopers Oy, Authorized Public Accountants, will continue as the company’s auditor. It was also resolved that the auditor’s fee will be paid as per approved invoice. Ylva Eriksson, Authorized Public Accountant, will continue as chief auditor. B. RESOLUTIONS OF THE BOARD OF DIRECTORS’ CONSTITUTIVE MEETING From among its members, the Board of Directors elected Mika Ihamuotila as Chairman of the Board and Elina Björklund as Vice Chairman of the Board. The Board also elected Elina Björklund as Chairman and Mikko-Heikki Inkeroinen and Catharina Stackelberg-Hammarén as members of the Audit and Remuneration Committee. All members of the committee are independent of the company and its major shareholders. C. MINUTES OF THE ANNUAL GENERAL MEETING The minutes of the Annual General Meeting can be viewed on the company’s website at company.marimekko.com under Investors/Management/General Meeting as of 20 April 2017 at the latest. MARIMEKKO CORPORATION Corporate Communications Piia Kumpulainen Tel. +358 9 758 7293 piia.kumpulainen@marimekko.com DISTRIBUTION: Nasdaq Helsinki Ltd Key media Marimekko is a Finnish design company renowned for its original prints and colours. The company’s product portfolio includes high-quality clothing, bags and accessories as well as home décor items ranging from textiles to tableware. When Marimekko was founded in 1951, its unparalleled printed fabrics gave it a strong and unique identity. Marimekko products are sold in about 40 countries. In 2016, brand sales of the products worldwide amounted to EUR 194 million and the company's net sales were close to EUR 100 million. Roughly 160 Marimekko stores serve customers around the globe. The key markets are Northern Europe, North America and the Asia-Pacific region. The Group employs about 400 people. The company’s share is quoted on Nasdaq Helsinki Ltd. www.marimekko.com

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Step Inside Henson's Creature Shop Magic in NYC

Unlock Puppet Magic with Jim Henson Tours Puppet fans, let me tell you, there's something going on in Queens, NY that's got both nostalgia and innovation scribbled all over it. We're talking about the legendary Jim Henson's Creature Shop opening its doors. If you're looking to relive the magic that helped shape a generation, get ready to dive into a world where creativity...

Streamlined AI Video Analytics for Public Safety Unveiled

AI Without the Headache Alright folks, IREX is shaking things up, and not in the usual iterative, bit-by-bit tech progression way. StreamVLM™ has been rolled out as the world's first vision-language model (VLM) analytics engine tailored for the public safety sector—specifically, for cloud platforms. I’ve been around the block enough times to spot a significant shift...

Lick the Plate Hits 2,000 Shows with Clown Band

They say good things come in bizarre packages, and that's exactly the case as David Boylan's Lick the Plate zany celebration marks 15 years on air with its 2,000th episode. If you think of radio as a predictable endeavor, well, you're not tuned into Lick the Plate. A Milepost Draped in Multicolored Fabrics When you're browsing through colorful avenues of radio fame, it's...

Intus Bio Secures $2.7M for Colorectal Cancer Test

Pioneering Efforts in Early-Onset Colorectal Cancer Detection The battlefield of colorectal cancer prevention just got a serious upgrade with Intus Bio grabbing a $2.7 million award. This ain't just pocket change—it's a shot at rewriting the script on how we approach early-onset colorectal cancer, the pesky number one cancer gnawing at the under-50 crowd. Partnering...

Oil Markets Shift Focus: Pipelines Trump Drilling

Decoupling Oil Price and Production Response This oil market isn’t your usual rodeo. With Brent flirting with $100, it’s a seismic shift that’s not yielding new drills but redirecting capital to the existing infrastructure landscape. Ask yourself why we're not seeing the usual cavalry charge of new rigs. It’s simple: Pipeline mileage and producing wells have...

Crystal Risotti: Leading IT Compliance in Healthcare

A Journey Marked by Dedication and Expertise In the demanding world of healthcare technology, where regulations can make or break a company, Crystal Risotti has carved out a space for herself as a leader. Over the last 30 years, she's developed a reputation for blending regulatory expertise with practical business strategies. Her recognition as a Pinnacle Professional of...

Bitwise Pulls Plug on Dogecoin ETF Amid Market Risks

Bitwise Ditches Dogecoin ETF: End of a Speculative Era Who knew that a digital asset inspired by an internet meme would get a platform on Wall Street? Well, Bitwise did. They rallied behind Dogecoin, launching the Bitwise Dogecoin ETF, ticker BWOW. But as of September 10, 2026, the fund's journey is coming to an end with liquidation just around the corner. What Sparked...

XKL Delivers MediaLight for High-Speed Optical Transport

Unpacking the MediaLight Launch Kicking off September, XKL is tossing its hat in the ring with the MediaLight Xponder and Muxponder systems. These aren't just any run-of-the-mill gizmos—nope, they're touted as top-of-the-line optical transport solutions. The talk of the town is their ability to dish out high-density 100G and 400G transport, and for geeks in the trade,...

Seismic Pharma Kicks Off Phase 3 Trial for Istaroxime

Seismic Sets the Stage for a Medical Milestone From the heart of biotech in Durham, North Carolina, seismic waves ripple through the medical community as Seismic Pharmaceuticals embarks on a high-stakes adventure. It's official: they've enrolled their very first patient in the global Phase 3 trial of istaroxime, targeting the grim specter known as cardiogenic shock. You...

Fermi's Founder Pushes for Board Overhaul: What's Next?

Fermi's Roller Coaster: A Founder’s Stand Seems like Fermi Inc. is on a wild ride through the business landscape, and it's giving shareholders more whiplash than satisfaction these days. Toby Neugebauer, co-founder of Fermi and the loudest voice in the room, is feeling like his company is facing some serious turbulence and seems determined not to sit idly by as it hits...